Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Copeptin Changes After Food Intake (CoMeal)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Mirjam Christ-Crain, University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT01772914
First received: January 17, 2013
Last updated: May 19, 2014
Last verified: January 2013
  Purpose

The purpose of this study is to determine whether copeptin levels are affected by food intake.


Condition
Healthy Adults
Copeptin

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Copeptin During a Standardized Oral Glucose Tolerance Test and a Mixed Meal Tolerance Test

Further study details as provided by University Hospital, Basel, Switzerland:

Primary Outcome Measures:
  • Changes in copeptin levels after intake of a oral glucose tolerance test- and a mixed meal tolerance test liquid [ Time Frame: 30, 60, 90, 120, 180 minutes after intake of the test liquids ] [ Designated as safety issue: No ]

Biospecimen Description:

Serum EDTA


Enrollment: 30
Study Start Date: February 2013
Study Completion Date: February 2014
Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

healthy adults

Criteria

Inclusion Criteria:

  • Aged over 18 years

Exclusion Criteria:

  • Intake of any kind of medication (except birth control pill)
  • BMI >30 kg/m2
  • Evidence of any acute illness
  • History of chronic illness
  • Pregnancy
  • Known galactosemia or maltose malabsorption
  • Baseline glucose level >5.5 mmol/l Baseline sodium level <135 mmol/l or >145 mmol/l
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01772914

Locations
Switzerland
University Hospital Basel
Basel, Basel-Stadt, Switzerland, 4031
Sponsors and Collaborators
University Hospital, Basel, Switzerland
Investigators
Principal Investigator: Mirjam Christ-Crain, Prof.Dr.med.
  More Information

No publications provided

Responsible Party: Mirjam Christ-Crain, Prof. Dr. med., University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier: NCT01772914     History of Changes
Other Study ID Numbers: CoMeal 2013
Study First Received: January 17, 2013
Last Updated: May 19, 2014
Health Authority: Switzerland: Swissmedic

Keywords provided by University Hospital, Basel, Switzerland:
Copeptin
eating
glucose tolerance test
mixed meal test
physiological

ClinicalTrials.gov processed this record on November 27, 2014